David W. Denning researcher
Denning, David W.
Denning, David W., 19..-...., spécialiste des maladies infectieuses
VIAF ID: 284360981 (Personal)
Permalink: http://viaf.org/viaf/284360981
Preferred Forms
-
100 0 _ ‡a David W. Denning ‡c researcher
-
100 1 _ ‡a Denning, David W
-
100 1 0 ‡a Denning, David W.
-
-
-
100 1 _ ‡a Denning, David W.
-
-
100 1 _ ‡a Denning, David W. (sparse)
-
100 1 _ ‡a Denning, David W., ‡d 19..-...., ‡c spécialiste des maladies infectieuses
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
The burden of fungal infections in Algeria |
![]() |
Epidemiology of fungal infections in HIV infected individuals in France : P jirovecii pneumonia and invasive aspergillosis in FHDH ANRS CO4 |
![]() |
Infections fongiques chez les patients infectés par le VIH à l'ère des combinaisons antirétrovirales (cART) : étude des pneumocystoses et aspergilloses invasives sur la base FHDH. |
![]() |
Laboratory diagnosis of invasive aspergillosis. |
![]() |
Long-term antifungal treatment improves health status in patients with chronic pulmonary aspergillosis: a longitudinal analysis |
![]() |
Mannose-binding lectin genotype and serum levels in patients with chronic and allergic pulmonary aspergillosis. |
![]() |
Measurement of aflatoxin in Nigerian sera by enzyme-linked immunosorbent assay |
![]() |
Medicine, 1997: |
![]() ![]() |
Medicine : a core text with self-assessment |
![]() |
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis |
![]() |
Microbial yield from physiotherapy assisted sputum production in respiratory outpatients |
![]() |
Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized |
![]() |
Molecular detection and identification of zygomycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection S |
![]() |
Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. |
![]() |
Multi-country estimate of different manifestations of aspergillosis in cystic fibrosis |
![]() |
Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay |
![]() |
Multilocus sequence typing of Candida glabrata reveals geographically enriched clades |
![]() |
Mutations in EEA1 are associated with allergic bronchopulmonary aspergillosis and affect phagocytosis of Aspergillus fumigatus by human macrophages. |
![]() |
Mycetoma in Uganda: A neglected tropical disease |
![]() |
Mycobacterium chelonae finger infection associated with Raynaud's phenomenon |
![]() |
Myocarditis complicating ethylene glycol poisoning in the absence of neurological features |
![]() |
Name changes in medically important fungi and their implications for clinical practice. |
![]() |
National trends in incidence, prevalence and disability-adjusted life years of invasive aspergillosis in Iran: a systematic review and meta-analysis |
![]() |
Nebulised -Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature |
![]() |
Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses |
![]() |
Neuralgic amyotrophy due to parvovirus infection |
![]() |
New and emerging treatments for fungal infections |
![]() |
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis |
![]() |
Novel immunologic classification of aspergillosis in adult cystic fibrosis. |
![]() |
Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing |
![]() |
Pathogenicity of Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice |
![]() |
Patients with suspected Lassa fever in London during 1984. |
![]() |
Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy |
![]() |
Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis |
![]() |
Peripheral neuropathy in patients on long-term triazole antifungal therapy |
![]() |
PERIPHERAL SYMMETRICAL GANGRENE SUCCESSFULLY TREATED WITH EPOPROSTENOL AND TISSUE PLASMINOGEN ACTIVATOR |
![]() |
Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect |
![]() |
Polar lipids of Aspergillus fumigatus, A. niger, A. nidulans, A. flavus and A. terreus. |
![]() |
Polarized Growth of Fungal Hyphae Is Defined by an Alkaline pH Gradient |
![]() |
Polymorphisms in Toll‐Like Receptor Genes and Susceptibility to Pulmonary Aspergillosis |
![]() |
Posaconazole responsive cerebral aspergillosis in an immunocompetent adult. |
![]() |
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America |
![]() |
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. |
![]() |
Pulmonary and sinus fungal diseases in non-immunocompromised patients |
![]() |
Pulmonary aspergillosis: an alternative diagnosis to lung cancer after positive [18F]FDG positron emission tomography |
![]() |
Pulmonary aspergillosis in a patient with chronic granulomatous disease: confirmation by polymerase chain reaction and serological tests, and successful treatment with voriconazole |
![]() |
Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK Intensive Care Units |
![]() |
Quantifying Deaths from Aspergillosis in HIV Positive People |
![]() |
Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study |
![]() |
Rapid genotyping of Escherichia coli O157 isolates by random amplification of polymorphic DNA. |
![]() |
Recovery from serious fungal infections should be realisable for everyone |
![]() |
Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in Chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT. |
![]() |
Relative reactivity ofAspergillusallergens used in serological tests |
![]() |
Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan". |
![]() |
Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug |
![]() |
Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence--a National Centre's experience |
![]() |
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC |
![]() |
Sarcoidosis and aspergillosis: a tough combination. |
![]() |
Scedosporium prolificans, a multi-resistant fungus, from a U.K. AIDS patient. |
![]() |
Sequencing the Aspergillus fumigatus genome |
![]() ![]() |
Serious fungal diseases in the Republic of Uzbekistan. |
![]() |
Skin rash after triple vaccine |
![]() |
Standards of care for patients with invasive fungal infections within the United Kingdom: a national audit |
![]() |
Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2) |
![]() |
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome |
![]() |
Sub-cutaneous phaeohyphomycosis caused by Cladophialophora devriesii in a United Kingdom resident. |
![]() |
Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis |
![]() |
Surface response modeling to examine the combination of amphotericin B deoxycholate and 5-fluorocytosine for treatment of invasive candidiasis |
![]() |
Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivo |
![]() |